ZENALB

This brand name is authorized in Cyprus, Israel, Malta, Singapore, Turkey, United Kingdom

Active ingredients

The drug ZENALB contains one active pharmaceutical ingredient (API):

1 Albumin UNII ZIF514RVZR - ALBUMIN HUMAN

Human albumin accounts quantitatively for more than half of the total protein in the plasma and represents about 10% of the protein synthesis activity of the liver. The most important physiological functions of albumin results from its contribution to oncotic pressure of the blood and transport function. Albumin stabilises circulating blood volume and is a carrier of hormones, enzymes, medicinal products and toxins. Read about Albumin

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
B05AA01	Albumin	B Blood and blood forming organs → B05 Blood substitutes and perfusion solutions → B05A Blood and related products → B05AA Blood substitutes and plasma protein fractions
Discover more medicines within B05AA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 44930, 44933, 44936, 44939
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 6899, 6900
Country: MT	Medicines Authority	Identifier(s): MA1320/00401, MA1320/00402
Country: SG	Health Sciences Authority	Identifier(s): 07170P, 07171P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8697507980021